Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients
about
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsApproaches to isolation and molecular characterization of disseminated tumor cellsSingle cell transcriptomic analysis of prostate cancer cellsProstate cancer invasion and metastasis: insights from mining genomic data.Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Molecular genetics of prostate cancer: new prospects for old challengesIsolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.Circulating tumor cells as biomarkers in prostate cancer.A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors.Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.Mechanisms of cancer cell metastasis to the bone: a multistep process.MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate CancerGenomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratificationBlood and tissue biomarkers in prostate cancer: state of the art.Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.Prognostic determinants in prostate cancer.Dormancy in solid tumors: implications for prostate cancer.The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.Advances in genomic characterization of circulating tumor cells.Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.Drug discovery in advanced prostate cancer: translating biology into therapy.DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.Extensive copy-number variation of the human olfactory receptor gene familyA transgenic mouse model for early prostate metastasis to lymph nodes.Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?The Role of Chromosomal Instability in Cancer and Therapeutic Responses.Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer
P2860
Q21202037-D662BB1B-155C-4F6D-B5AE-C3C6C4C65F1AQ26748850-3AE8C689-2A7E-409C-B246-A1F2EDE7D571Q26785829-43ED16DA-79D9-4D8C-9AC8-AA4D9D27711BQ30537663-006999ED-97EB-4F1A-91DF-B8C3A0D10FAFQ30656758-1BF9E8CB-DE3F-4FB7-9F3A-4A754B35802CQ33894922-A199BBFB-E174-4C06-88EC-2854AF7AD034Q34127462-10EDD8BF-B613-4B09-B927-94D4EA12C515Q34176352-7887CF59-A5A6-4AC7-9B56-BD051DF3F0E2Q34193303-8BBFB08B-4BAD-4248-833B-F17CDECFB662Q35009891-5D53DC47-427E-4A04-A046-425179EB0C5CQ35225370-1E2446FD-7606-4F90-A587-38E1637B035AQ35345680-D55FD8C4-2F61-4D6F-963E-1C22D42E5F9DQ35579435-C79CF970-17A6-422C-A993-FF443BF3C073Q35673417-FA61C534-B0C2-4A6B-841F-27C786847E21Q36301750-FFD3F719-4B07-426E-86D5-C2CC216837CDQ36468773-2D7A5C95-787A-4FDA-AE07-A0898B6537E6Q37067529-11260C6A-1FA4-46DC-BF41-0A825C35DC3CQ37201929-5291FFC5-0A2D-4B3E-A1B7-A17CF34910BCQ37408608-C9A5F7D9-4816-48EE-B97B-717FB89FC775Q37966912-3F08988F-44BD-4264-96CD-8FD837C79432Q38101246-455040FB-AC72-4A1E-8C8C-7000407511D6Q38213416-CA4487BB-DB37-4D38-8EBA-CAD0D0A927BAQ38215455-DF458CAD-D693-43A4-B931-B2D982616CFBQ38263525-02820DFC-6262-408F-9A49-CE154C4F02D6Q38839110-41B4AFFF-DD1A-42F1-87B6-E0B1CEEC927DQ39347119-B3F61694-0525-4652-8929-D55600785AB5Q41257340-1886F7B9-2BAC-4910-AC9A-6A242EB3C9DAQ41864582-18E3A575-8895-4A8E-81CB-379130D334D0Q42220108-85C6C10A-A498-4760-B9CA-DDC54D15ECAFQ42370830-273875C3-B5B4-4689-B0E5-9C7C70CC39AEQ42575291-49E2FB7B-BE85-4962-8B8A-01FDBAEC6D49Q47570870-C3A6B0F4-B460-471C-9505-CF13DB10CDFBQ58763412-C622ADB6-2886-4EC2-94AC-8C57DB0887F5
P2860
Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genomic alterations indicate t ...... from prostate cancer patients
@ast
Genomic alterations indicate t ...... from prostate cancer patients
@en
type
label
Genomic alterations indicate t ...... from prostate cancer patients
@ast
Genomic alterations indicate t ...... from prostate cancer patients
@en
prefLabel
Genomic alterations indicate t ...... from prostate cancer patients
@ast
Genomic alterations indicate t ...... from prostate cancer patients
@en
P2093
P2860
P1433
P1476
Genomic alterations indicate t ...... from prostate cancer patients
@en
P2093
Barbara J Trask
Cassandra L Sather
Cynthia L Friedman
Douglas I Grove
Ian S Gallaher
Ilona N Holcomb
Janet M Young
Jeffrey J Delrow
Lawrence D True
P2860
P304
P356
10.1158/0008-5472.CAN-08-0812
P407
P577
2008-07-01T00:00:00Z